New York Proton Center joins RadComp clinical trial evaluating proton v. photon therapy in non-metastatic breast cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The New York Proton Center is joining the first national randomized clinical trial to evaluate the efficacy of proton therapy compared to traditional radiotherapy for patients with locally advanced breast cancer.

To access this subscriber-only content please log in or renew you subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
In This Issue

YOU MAY BE INTERESTED IN

Login